(19)
(11) EP 1 012 292 A1

(12)

(43) Date of publication:
28.06.2000 Bulletin 2000/26

(21) Application number: 98925109.5

(22) Date of filing: 03.06.1998
(51) International Patent Classification (IPC)7C12N 15/19, C07K 14/52, C07K 16/24, C07K 19/00, A61K 38/19, C12Q 1/68, A61K 39/395
(86) International application number:
PCT/US9811/153
(87) International publication number:
WO 9855/620 (10.12.1998 Gazette 1998/49)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 06.06.1997 US 48776 P
21.11.1997 US 66386 P

(71) Applicant: REGENERON PHARMACEUTICALS, INC.
Tarrytown, NY 10591-6707 (US)

(72) Inventors:
  • MASIAKOWSKI, Piotr
    Pleasant Valley, NY 12569 (US)
  • VALENZUELA, David
    Franklin Square, NY 11010 (US)

(74) Representative: Goldin, Douglas Michael et al
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) NTN-2 MEMBER OF TNF LIGAND FAMILY